Literature DB >> 12898138

Clinical analysis of extranodal non-Hodgkin's lymphoma in the sinonasal tract.

J-S Woo1, J M Kim, S H Lee, S W Chae, S J Hwang, H-M Lee.   

Abstract

We investigated the clinical analysis of non-Hodgkin's lymphoma (NHL) of the sinonasal tract, including the survival rate and treatment outcome. Fifty patients who had previously received a diagnosis of extranodal NHL of the sinonasal cavity from May 1992 to April 2001 were included. We reviewed the patients' clinical characteristics and the survival rates, retrospectively. Of 50 patients, 49 were classified as having extranodal NK/T cell lymphoma and only one patient as having diffuse large B cell (DLBC) lymphoma according to the new WHO classification. Even though higher mortality rates were observed in patients receiving chemotherapy alone than in those receiving chemotherapy and radiation therapy in the advanced stage, the combination treatment of chemotherapy and radiation therapy failed to demonstrate a significantly higher survival rate.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12898138     DOI: 10.1007/s00405-003-0627-6

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  31 in total

1.  Non-Hodgkin's malignant lymphoma of the sinonasal tract--treatment outcome for 53 patients according to REAL classification.

Authors:  C Hatta; H Ogasawara; J Okita; A Kubota; M Ishida; M Sakagami
Journal:  Auris Nasus Larynx       Date:  2001-01       Impact factor: 1.863

2.  Extranodal head and neck lymphomas in Guatemala: high frequency of Epstein-Barr virus-associated sinonasal lymphomas.

Authors:  M van de Rijn; V Bhargava; H Molina-Kirsch; R Carlos-Bregni; R A Warnke; M L Cleary; O W Kamel
Journal:  Hum Pathol       Date:  1997-07       Impact factor: 3.466

Review 3.  Extranodal peripheral T-cell and NK-cell neoplasms.

Authors:  E S Jaffe; L Krenacs; S Kumar; D W Kingma; M Raffeld
Journal:  Am J Clin Pathol       Date:  1999-01       Impact factor: 2.493

4.  Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma.

Authors:  R I Fisher; E R Gaynor; S Dahlberg; M M Oken; T M Grogan; E M Mize; J H Glick; C A Coltman; T P Miller
Journal:  N Engl J Med       Date:  1993-04-08       Impact factor: 91.245

5.  Treatment of lethal midline granuloma type nasal T-cell lymphoma.

Authors:  K Sakata; M Hareyama; A Ohuchi; M Sido; H Nagakura; K Morita; Y Harabuchi; A Kataura
Journal:  Acta Oncol       Date:  1997       Impact factor: 4.089

6.  Tumor bulk as a prognostic factor for the management of localized aggressive non-Hodgkin's lymphoma: a survey of the Japan Lymphoma Radiation Therapy Group.

Authors:  M Oguchi; H Ikeda; K Isobe; S Hirota; M Hasegawa; K Nakamura; K Sasai; N Hayabuchi
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-08-01       Impact factor: 7.038

7.  Head-and-neck stages I and II extranodal non-Hodgkin's lymphomas: real classification and selection for treatment modality.

Authors:  K Sasai; H Yamabe; M Kokubo; T Shibata; N Oya; Y Nagata; M Hiraoka
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-08-01       Impact factor: 7.038

8.  CHOP followed by involved field radiation: is it optimal for localized nasal natural killer/T-cell lymphoma?

Authors:  W S Kim; S Y Song; Y C Ahn; Y H Ko; C H Baek; D Y Kim; S S Yoon; H G Lee; W K Kang; H J Lee; C H Park; K Park
Journal:  Ann Oncol       Date:  2001-03       Impact factor: 32.976

9.  Clinico-pathological features of malignant lymphomas in 294 Hong Kong Chinese patients, retrospective study covering an eight-year period.

Authors:  F C Ho; D Todd; S L Loke; R P Ng; R K Khoo
Journal:  Int J Cancer       Date:  1984-08-15       Impact factor: 7.396

10.  Most nasal/nasopharyngeal lymphomas are peripheral T-cell neoplasms.

Authors:  J K Chan; C S Ng; W H Lau; S T Lo
Journal:  Am J Surg Pathol       Date:  1987-06       Impact factor: 6.394

View more
  3 in total

1.  Clinical findings of extranodal SNT lymphoid malignancies in a four-decade single-centre series.

Authors:  Pauli Vähämurto; Kaija Silventoinen; Seija I Vento; Marja-Liisa Karjalainen-Lindsberg; Aaro Haapaniemi; Leif Bäck; Susanna Mannisto; Sirpa Leppä; Antti A Mäkitie
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-03-24       Impact factor: 2.503

2.  The diagnosis of sinonasal lymphoma: a challenge for rhinologists.

Authors:  Ting-Ting Yen; Ren-Ching Wang; Rong-San Jiang; Shyh-Chang Chen; Shang-Heng Wu; Kai-Li Liang
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-11-26       Impact factor: 2.503

3.  Sinonasal natural killer/T-cell lymphoma presenting as pyrexia of unknown origin with nasal symptoms.

Authors:  Betsy K H Soon; Xin-Rong Lim; Deborah H L Ng; Ming-Yann Lim
Journal:  Singapore Med J       Date:  2014-07       Impact factor: 1.858

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.